Yongyan Zhou
Overview
Explore the profile of Yongyan Zhou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang K, Yang L, Li Q, Yang X, Chen Z, Zhou Y, et al.
J Inflamm Res
. 2024 Jul;
17:4791-4810.
PMID: 39051052
Background: Ischemic stroke (IS) is one of the leading causes of death and disability in the world, and alcohol consumption has been gaining attention as an independent risk factor for...
2.
Yao Y, Yang X, Zhou Y, Xie H, Duan R, Jing L, et al.
Front Neurol
. 2022 Sep;
13:969762.
PMID: 36090884
Background: The coexistence of neuromyelitis optica spectrum disorder (NMOSD) and connective tissue disease (CTD) is well recognized. The purpose of this study was to investigate and compare the characteristics of...
3.
Duan R, Sun K, Fang F, Wang N, He R, Gao Y, et al.
J Nanobiotechnology
. 2022 Aug;
20(1):397.
PMID: 36045405
Background: Ischemic stroke is one of the most serious global public health problems. However, the performance of current therapeutic regimens is limited due to their poor target specificity, narrow therapeutic...
4.
Bai L, Zhou Y, Zhang P, Li S
ACS Omega
. 2022 Jan;
7(1):351-361.
PMID: 35036705
Removing heavy metal ions from water is an important issue to improve water quality. However, using cost-effective and more environmentally friendly adsorbents to achieve efficient adsorption capacity remains a challenge....
5.
Li Y, Xie H, Zhang J, Zhou Y, Jing L, Yao Y, et al.
Front Immunol
. 2022 Jan;
12:752557.
PMID: 34975841
Objective: To analyze and compare different clinical, laboratory, and magnetic resonance imaging characteristics between pediatric and adult patients with first-attack myelin oligodendrocyte glycoprotein antibody disease (MOGAD) and to explore predictive...
6.
Zhang J, Li Y, Zhou Y, Wang K, Pan C, Zhao Y, et al.
Front Neurol
. 2021 Nov;
12:763793.
PMID: 34777231
To investigate the association of monocyte to high-density lipoprotein ratio (MHR) with disease severity and prognosis in patients with neuromyelitis optica spectrum disorders (NMOSD). This retrospective study included 125 patients...
7.
Xie H, Zhao Y, Pan C, Zhang J, Zhou Y, Li Y, et al.
BMC Neurol
. 2021 Oct;
21(1):389.
PMID: 34625035
Background: To investigate the relationship between the neutrophil-to-lymphocyte ratio (NLR) and prognosis after the first attack of optic neuromyelitis optica spectrum disorder (NMOSD). Methods: In this retrospective study, we included...
8.
Pan C, Zhao Y, Xie H, Zhou Y, Duan R, Li Y, et al.
Neuropsychiatr Dis Treat
. 2021 Sep;
17:2859-2866.
PMID: 34522097
Purpose: To describe and compare the clinical features of patients with first-episode neuromyelitis optica spectrum disorder (NMOSD) in a normal complement C4 group and a low complement C4 group, and...
9.
Li Y, Zhang J, Zhou Y, Xie H, Duan R, Jing L, et al.
Front Neurol
. 2021 Sep;
12:731835.
PMID: 34512539
Neuromyelitis optica spectrum disorders (NMOSDs) are inflammatory diseases with a high risk of recurrence and progressive disability, and it is crucial to find sensitive and reliable biomarkers for prognosis and...
10.
Zhang J, Li Y, Zhou Y, Zhao Y, Xie H, Duan R, et al.
Front Neurol
. 2021 Jun;
12:667651.
PMID: 34122309
Many patients with neuromyelitis optica spectrum disorders (NMOSD) experience the adverse consequences of relapse and disability aggravation. Thus, it is necessary to identify sensitive and reliable biomarkers for early prognosis....